BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34207886)

  • 1. Preservation of Contractile Reserve and Diastolic Function by Inhibiting the NLRP3 Inflammasome with OLT1177
    Aliaga J; Bonaventura A; Mezzaroma E; Dhakal Y; Mauro AG; Abbate A; Toldo S
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse.
    Toldo S; Mauro AG; Cutter Z; Van Tassell BW; Mezzaroma E; Del Buono MG; Prestamburgo A; Potere N; Abbate A
    J Cardiovasc Pharmacol; 2019 Apr; 73(4):215-222. PubMed ID: 30747785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis.
    Marchetti C; Swartzwelter B; Koenders MI; Azam T; Tengesdal IW; Powers N; de Graaf DM; Dinarello CA; Joosten LAB
    Arthritis Res Ther; 2018 Aug; 20(1):169. PubMed ID: 30075804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease.
    Lonnemann N; Hosseini S; Marchetti C; Skouras DB; Stefanoni D; D'Alessandro A; Dinarello CA; Korte M
    Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32145-32154. PubMed ID: 33257576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1β blockade improves left ventricular systolic/diastolic function and restores contractility reserve in severe ischemic cardiomyopathy in the mouse.
    Toldo S; Mezzaroma E; Bressi E; Marchetti C; Carbone S; Sonnino C; Van Tassell BW; Abbate A
    J Cardiovasc Pharmacol; 2014 Jul; 64(1):1-6. PubMed ID: 25006675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
    Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH
    Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
    Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis.
    Sánchez-Fernández A; Skouras DB; Dinarello CA; López-Vales R
    Front Immunol; 2019; 10():2578. PubMed ID: 31736980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction.
    Gao R; Shi H; Chang S; Gao Y; Li X; Lv C; Yang H; Xiang H; Yang J; Xu L; Tang Y
    Int Immunopharmacol; 2019 Sep; 74():105575. PubMed ID: 31299609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Orally Available NLRP3 Inflammasome Inhibitor Prevents Western Diet-Induced Cardiac Dysfunction in Mice.
    Carbone S; Mauro AG; Prestamburgo A; Halquist MS; Narayan P; Potere N; Mezzaroma E; Van Tassell BW; Abbate A; Toldo S
    J Cardiovasc Pharmacol; 2018 Dec; 72(6):303-307. PubMed ID: 30422890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse.
    Toldo S; Marchetti C; Mauro AG; Chojnacki J; Mezzaroma E; Carbone S; Zhang S; Van Tassell B; Salloum FN; Abbate A
    Int J Cardiol; 2016 Apr; 209():215-20. PubMed ID: 26896627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phloretin ameliorates heart function after myocardial infarction via NLRP3/Caspase-1/IL-1β signaling.
    Li B; Xu L; Liu J; Zhou M; Jiang X
    Biomed Pharmacother; 2023 Sep; 165():115083. PubMed ID: 37413902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X
    Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F
    J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse.
    Marchetti C; Toldo S; Chojnacki J; Mezzaroma E; Liu K; Salloum FN; Nordio A; Carbone S; Mauro AG; Das A; Zalavadia AA; Halquist MS; Federici M; Van Tassell BW; Zhang S; Abbate A
    J Cardiovasc Pharmacol; 2015 Jul; 66(1):1-8. PubMed ID: 25915511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury.
    Amo-Aparicio J; Garcia-Garcia J; Puigdomenech M; Francos-Quijorna I; Skouras DB; Dinarello CA; Lopez-Vales R
    Exp Neurol; 2022 Jan; 347():113889. PubMed ID: 34624330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperazine ferulate protects against cardiac ischemia/reperfusion injury in rat via the suppression of NLRP3 inflammasome activation and pyroptosis.
    Lei Z; Luan F; Zhang X; Peng L; Li B; Peng X; Liu Y; Liu R; Zeng N
    Eur J Pharmacol; 2022 Apr; 920():174856. PubMed ID: 35219728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NLRP3 inhibitor, OLT1177 attenuates brain injury in experimental intracerebral hemorrhage.
    Fang M; Xia F; Wang J; Wang C; Teng B; You S; Li M; Chen X; Hu X
    Int Immunopharmacol; 2024 Apr; 131():111869. PubMed ID: 38492343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
    Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
    Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroacupuncture preconditioning attenuates acute myocardial ischemia injury through inhibiting NLRP3 inflammasome activation in mice.
    Zhang T; Yang WX; Wang YL; Yuan J; Qian Y; Sun QM; Yu ML; Fu SP; Xu B; Lu SF
    Life Sci; 2020 May; 248():117451. PubMed ID: 32088213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction.
    van Hout GP; Bosch L; Ellenbroek GH; de Haan JJ; van Solinge WW; Cooper MA; Arslan F; de Jager SC; Robertson AA; Pasterkamp G; Hoefer IE
    Eur Heart J; 2017 Mar; 38(11):828-836. PubMed ID: 27432019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.